BrightPath Biotherapeutics Co (TSE:4594) 3-Year EBITDA Growth Rate : 16.30% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co 3-Year EBITDA Growth Rate?

BrightPath Biotherapeutics Co's EBITDA per Share for the three months ended in Dec. 2023 was 円-6.12.

During the past 3 years, the average EBITDA Per Share Growth Rate was 16.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of BrightPath Biotherapeutics Co was 16.30% per year. The lowest was -22.30% per year. And the median was -0.85% per year.

Competitive Comparison of BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate falls into.

BrightPath Biotherapeutics Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

BrightPath Biotherapeutics Co (TSE:4594) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

BrightPath Biotherapeutics Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BrightPath Biotherapeutics Co (TSE:4594) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN

Website

https://www.brightpathbio.com

BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines